ClinicalTrials.gg
RecruitingNCT04286308Updated Mar 25, 2026

Cortical-Basal Ganglia Speech Networks

An interventional study of electrophysiological data collection in Parkinson Disease, Essential Tremor and Dystonia, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-03-25.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Oct 2020; still recruiting 6 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Not applicable
Ages
18 Years to 85 Years
Sex
All
01

Study summary

In this research study the researchers want to learn more about brain activity related to speech perception and production.

Read the detailed description

Speech production is disrupted in a number of neurological diseases that involve the basal ganglia, including Parkinson's disease (PD) and dystonia. The investigators will use a novel experimental approach and combination of analytic techniques to elucidate the contribution of neural activity in cortical-basal ganglia circuits to the hierarchical control of speech production, in subjects undergoing deep brain stimulation surgery.

02

Conditions studied

  • Parkinson Disease
  • Essential Tremor
  • Dystonia
03

In context

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

This study's planned enrollment of 80 is above the median of 40 across 3,353 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,586 studies on the registry; 447 are open to participants now.

Of its 222 completed or terminated interventional studies of FDA-regulated products, 168 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease, essential tremor or dystonia.
  2. Subjects able to provide and comply with task instructions.
  3. Subjects 18-85 years old

Exclusion criteria

Exclusion Criteria:

  1. Subjects with reported hearing loss.
  2. Non-English-speaking subjects
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Brain signal data collection

    Brain signal data collection at the time of deep brain stimulation (DBS) surgery.

    Other: electrophysiological data collection

Interventions

  • Otherelectrophysiological data collection

    Electrophysiological data collection at the time of DBS surgery.

06

What researchers measure

Primary outcomes

  1. The number of subjects providing the interpretable speech related electrophysiological data collection.

    The number of subjects providing the interpretable speech related electrophysiological data during DBS surgery.

    Time frame: Duration of single DBS surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04286308
Responsible party
Robert Mark Richardson (Director of Functional Neurosurgery, Massachusetts General Hospital) — Principal investigator
First posted
Feb 27, 2020
Start date
Oct 1, 2020
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Mar 25, 2026

Study contacts

Mark Richardson, MD, PhD
Contact
mark.richardson@mgh.harvard.edu
617-726-8849
Erin Donahue, PhD
Contact
ekdonahue@mgh.harvard.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion